Human papillomavirus and vulval intra-epithelial neoplasia

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 15, Issue 5, 2001, Pages 769-782

  Gastrell, Flora H ^a   McConnell, Dynes T ^a  

^a Capital Coast Health Limited   (New Zealand)

Author keywords

Disease management; Epidemiology; Human; Immunotherapy; Intra epithelial; Neoplasm; Oncogenes; p53; Papillomavirus; Therapeutics; Vulva; Vulval; Vulval neoplasm

Indexed keywords

ALPHA2B INTERFERON; AMINOLEVULINIC ACID; FLUOROURACIL; IMIDAZOQUINOLINE DERIVATIVE; IMIQUIMOD; IMMUNOMODULATING AGENT; INTROL A; PHOTOSENSITIZING AGENT; PRODRUG; PROTEIN P53; RETINOID DERIVATIVE; STEROID; VIRUS VACCINE;

BODY IMAGE; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CANCER RISK; CARCINOGENESIS; CLINICAL TRIAL; DISEASE ASSOCIATION; DISTRESS SYNDROME; DRUG TOLERABILITY; EPITHELIUM; GENE THERAPY; GYNECOLOGIC SURGERY; HEALTH SURVEY; HUMAN; MALIGNANT TRANSFORMATION; MORBIDITY; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SEXUAL FUNCTION; SKIN INFECTION; SQUAMOUS CELL CARCINOMA; VIRUS INFECTION; VIRUS MUTATION; VIRUS ONCOGENE; VULVA CANCER; VULVA CARCINOMA; VULVITIS; WART VIRUS;

EID: 0034747978     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1053/beog.2001.0219     Document Type: Article

References (73)

1. Premalignant and malignant tumours of the vulva
2. New nomenclature for vulvar disease. Report of the committee on terminology of the International Society for the Study of Vulvar Disease
3. The aetiology of vulval neoplasia
4. Inter-observer variation in histopathological diagnosis and grading of vulvar intraepithelial neoplasia: Results of a European collaborative study
5. Epidermoid carcinoma of the vulva: An analysis of 238 cases
6. Epithelial alterations in proximity to invasive squamous carcinoma of the vulva
7. The epithelial changes associated with squamous cell carcinoma of the vulva: A review of the clinical, histological and viral findings in 78 women
8. Benign and malignant disorders of the vulva
9. The under-reporting of skin disease in association with squamous cell carcinoma of the vulva
10. The significance of the histologic alterations adjacent to invasive vulvar carcinoma
11. Carcinoma of the vulva, urethra, and Bartholin's glands
12. Trends in gynaecological cancers in England and Wales
13. Vulvar intraepithelial neoplasia (severe atypia and carcinoma in situ): A clinicopathologic analysis of 41 cases
14. Carcinoma in situ of the vulva: 24 years experience in South West Florida
15. Vulvar intraepithelial neoplasia. A clinicopathologic study of 60 cases
16. Carcinoma in situ of the vulva
17. Vulvar intraepithelial neoplasia III: A clinical study of the outcome in 113 cases with relation to the later development of invasive vulvar carcinoma
18. Vulvar intraepithelial neoplasia. III. A viral disease of undetermined progressive potential
19. Vulvar intraepithelial neoplasia: Long term follow up of treated and untreated women
20. Vulval squamous cell carcinoma and pre-malignant skin conditions: A population-based study
21. In situ and invasive vulvar cancer incidence trends (1973 to 1987)
22. Genital human papillomavirus infection in female university students as determined by a PCR-based method
23. Human papillomavirus infection is transient in young women: A population-based cohort study
24. The role of papillomaviruses in anogenital cancer
25. The invasive potential of carcinoma in situ of the cervix
26. The effect of organised screening on the risk of cervical cancer in the Nordic countries
27. Accelerated decline in cervical cancer mortality in England and Wales
28. Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in pre-invasive disease
29. Invasive cervical cancer in Southampton and south west Hampshire: The effect of introducing a comprehensive screening programme
30. Prospective sero-epidemiological study of role of human papillomavirus in non-cervical anogenital cancers
31. Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: Results from a seroepidemiological case-control study
32. Intraepithelial and invasive neoplasia of the vulva in association with human papillomavirus infection
33. Molecular assessment of histopathological staging in squamous cell carcinoma of the head and neck
34. Sunburn and p53 in the onset of skin cancer
35. Human epidermal cancer and accompanying precursors have identical p53 mutations different from p53 mutations in adjacent areas of clonally expanded non-neoplastic keratinocytes
36. Carcinoma of the vulva: HPV and p53 mutations
37. Mutation of tumour suppresser gene p53 is frequently found in vulvar carcinoma cells
38. Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva
39. p53 mutations in HPV-negative cervical carcinoma
40. Expression of p53 in oesophageal squamous epithelium from surgical specimens resected for squamous carcinoma of the oesophagus, with special reference to uninvolved mucosa
41. p53 expression in multicentric squamous cell carcinoma and surrounding squamous epithelium of the upper aerodigestive tract
42. High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumours and metastases: Absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions
43. p53 expression: A potential biomarker for risk of multiple primary malignancies in the upper aerodigestive tract
44. Localisation of p53 protein and human papillomavirus in anogenital squamous lesions: Immunohistochemical and in-situ hybridisation studies in benign, dysplastic and malignant epithelia
45. Growth arrest and cell death: Key determinants of tissue homeostasis
46. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
47. High levels of p53 protein in UV-irradiated normal human skin
48. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer
49. Human papillomavirus infections in non-melanoma skin cancers from renal transplant recipients and non-immunosuppressed patients
50. Human papillomavirus infections in skin cancers
51. Human papillomaviruses
52. Detection of human papillomavirus deoxyribonucleic acid from vulvar dystrophies and vulvar intraepithelial neoplastic lesions
53. Lichen sclerosus, invasive squamous cell carcinoma and human papillomavirus
54. Human papillomavirus, vulvar dystrophy and vulvar carcinoma: Differential expression of human papillomavirus and vulvar dystrophy in the presence and absence of squamous cell carcinoma of the vulva
55. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage
56. Modulation of transcriptional regulatory properties of p53 by HPV E6
57. Vulvar intraepithelial neoplasia: Long term follow up of treated and untreated women
58. Lotus petal flaps in vulvo-vaginal reconstruction
59. Flap repair: An effective strategy for minimising sexual morbidity associated with the surgical management of vulval intra epithelial neoplasia
60. Sexual functioning after treatment of in situ vulvar cancer: Preliminary report
61. Psychosexual adjustment after vulvar surgery
62. Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy
63. Human papillomavirus vaccines for cervical cancer
64. Use of fluorogenic histocompatibility leukocyte antigen-A*0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigens
65. HPV vaccine treatment trials proliferate, diversify
66. Self-administered topical 5% imiquimod cream for external anogenital warts
67. A randomised, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod
68. Retroviral-mediated wild-type p53 gene transfer to tumours of patients with lung cancer
69. Photodynamic treatment for lower genital tract intraepithelial neoplasia
70. Photodynamic therapy of vulvar intraepithelial neoplasia using 5-aminolevulinic acid